1. Academic Validation
  2. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling

The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling

  • J Biol Chem. 2017 Sep 15;292(37):15180-15191. doi: 10.1074/jbc.M117.786764.
Franziska Dierck 1 2 Christian Kuhn 1 2 Claudia Rohr 3 Susanne Hille 1 2 Julia Braune 4 Samuel Sossalla 1 2 Sibylle Molt 4 Peter F M van der Ven 4 Dieter O Fürst 4 Norbert Frey 5 2
Affiliations

Affiliations

  • 1 From the Department of Internal Medicine III, University Medical Center of Schleswig-Holstein, 24105 Kiel.
  • 2 the DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, 24105 Kiel.
  • 3 the Department of Internal Medicine III, University of Heidelberg, 69120 Heidelberg, and.
  • 4 the Department of Molecular Cell Biology, Institute for Cell Biology, University of Bonn, 53121 Bonn, Germany.
  • 5 From the Department of Internal Medicine III, University Medical Center of Schleswig-Holstein, 24105 Kiel, [email protected].
Abstract

The z-disc is a structural component at the lateral borders of the sarcomere and is important for mechanical stability and contractility of both cardiac and skeletal muscles. Of note, the sarcomeric z-disc also represents a nodal point in cardiomyocyte function and signaling. Mutations of numerous z-disc proteins are associated with cardiomyopathies and muscle diseases. To identify additional z-disc proteins that might contribute to cardiac disease, we employed an in silico screen for cardiac-enriched cDNAs. This screen yielded a previously uncharacterized protein named c ardiac- e nriched F HL2- i nteracting p rotein (CEFIP), which exhibited a heart- and skeletal muscle-specific expression profile. Importantly, CEFIP was located at the z-disc and was up-regulated in several models of cardiomyopathy. We also found that CEFIP overexpression induced the fetal gene program and cardiomyocyte hypertrophy. Yeast two-hybrid screens revealed that CEFIP interacts with the calcineurin-binding protein four and a half LIM domains 2 (FHL2). Because FHL2 binds calcineurin, a Phosphatase controlling hypertrophic signaling, we examined the effects of CEFIP on the calcineurin/nuclear factor of activated T-cell (NFAT) pathway. These experiments revealed that CEFIP overexpression further enhances calcineurin-dependent hypertrophic signal transduction, and its knockdown repressed hypertrophy and calcineurin/NFAT activity. In summary, we report on a previously uncharacterized protein CEFIP that modulates calcineurin/NFAT signaling in cardiomyocytes, a finding with possible implications for the pathogenesis of cardiomyopathy.

Keywords

C10orf71; CEFIP; calcineurin; cardiac hypertrophy; cardiomyocyte; cardiomyopathy; cardiovascular disease; signaling; z-disc.

Figures